Immunosuppressive agents in dermatology

Dermatologic Clinics

Volumn 11, Issue 1, 1993, Pages 73-85

  Ho, V C ^a   Zloty, D M ^a  

^a Division of Dermatology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CARCINOGEN; CHEMICAL TERATOGEN; CHLORMETHINE; CIMETIDINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DEXAMETHASONE; DILTIAZEM; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; PHENOBARBITAL; PHENYTOIN; PHOSPHORAMIDE MUSTARD; PREDNISONE; PURINE DERIVATIVE; RIFAMPICIN; TRIMETHOPRIM; UNINDEXED DRUG; VERAPAMIL;

AUTOIMMUNITY; BEHCET DISEASE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG CARCINOGENICITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG THERAPY; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; LIVER TOXICITY; LUNG EMPHYSEMA; LUPUS ERYTHEMATOSUS; MOUSE; NEPHROTOXICITY; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PANCREATITIS; POLYMYOSITIS; POLYNEUROPATHY; RAT; REPRODUCTIVE TOXICITY; REVIEW; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; URINARY TRACT DISEASE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0027469551     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0733-8635(18)30284-5     Document Type: Review

References (165)

1. Aberer W. Wolff-Schreiner E.C. Stingl G. Azathioprine in the treatment of pemphigus vulgaris J Am Acad Dermatol 16 1987 527 533
2. Abeywickrama K. Baker B.S. Barnes A. A consensus report: Cyclosporin A therapy for psoriasis Br J Dermatol 122 36 1990 1 3
3. Ahmed A.R. Hombal S.M. Cyclophosphamide (Cytoxan): A review of relevant pharmacology and clinical uses J Am Acad Dermatol 11 1984 1115 1126
4. Ahmed A.R. Maize J.C. Provost T.T. Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy Arch Dermatol 113 1977 1043 1046
5. Alijotas J. Pedragosa R. Bosch J. Prolonged remission after cyclosporine therapy in pemphigus vulgaris: Report of two young siblings J Am Acad Dermatol 23 1990 701 703
6. Appelboom T. Itzkowitch D. Cyclosporine in successful control of rapidly progressive scleroderma Am J Med 82 1987 866 867
7. Ashinoff R. Werth V.P. Franks A.G. Jr Resistant discoid lupus erythematosus of palms and soles: Successful treatment with azathioprine J Am Acad Dermatol 19 1988 961 964
8. August P.J. Wells G.C. Pyoderma gangrenosum treated with azathioprine and prednisolone Br J Dermatol 91 10 1974 80
9. Balda B.R. Rosenzweig D. Cyclosporin A in der Behandlung von pemphigus foliaceus and pemphigus erythematosus Hautarzt 37 1986 454 457
10. Barnett E.V. Dornfield L. Dee D.B.N. Long-term survival of lupus nephritis patients treated with azathioprine and prednisolone J Rheum 5 1978 275 287
11. Barthelemy H. Frappaz A. Cambazard F. Treatment of nine cases of pemphigus vulgaris with cyclosporine J Am Acad Dermatol 18 1988 1262 1266
12. Bencini P.L. Montagnino G. Sala F. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients Dermatologica 172 1986 24 30
13. Bennett A.H. Cyclophosphamide and hemorrhagic cystitis J Urol 111 1974 603
14. Benson M.D. Aldo M.A. Washington D.C. Azathioprine therapy in polymyositis Arch Intern Med 132 1973 547
15. Bradley W.G. Walton J.N. Letter: Treatment of der-matomyositis Br Med J 2 1976 43
16. Brodell R.T. Miller C.W. Eisen A.Z. Cutaneous lesions of lymphomatoid granulomatosis Arch Dermatol 122 1986 303 306
17. Brody H.J. Pirozzi D.J. Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide Arch Dermatol 113 1977 1598 1599
18. Brown M.D. Ellis C.N. Billings J. Rapid occurrence of nodular cutaneous T-lymphocytic infiltrates with cyclosporine therapy Arch Dermatol 124 1988 1097 1100
19. Buckeley C.E. III Gillis J.R. Jr Cyclophosphamide therapy of Behcet's disease J Allergy Clin Immunol 43 1969 273 283
20. Bunch T.W. Long-term follow-up of azathioprine for polymyositis Arthritis Rheum 23 1980 658
21. Burton J.L. Greaves M.W. Azathioprine for pemphigus and pemphigoid. A 4-year follow-up Br J Dermatol 91 1974 103 109
22. Burton J.L. Harman R.M.M. Peachey R.D.G. A controlled study of azathioprine in the treatment of pemphigoid Br J Dermatol 99 16 1978 14
23. Callen J.P. Immunosuppressive and cytotoxic drugs: Uses in the dermatologic patient Adv Dermatol 5 1990 3 20
24. Callen J.P. af Ekenstam E. Cutaneous leukocyto-clastic vasculitis. Clinical experience in 44 patients South Med J 80 1987 848 851
25. Callen J.P. Spencer L.V. Burruss J.B. Azathioprine: An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leuko-cytoclastic vasculitis Arch Dermatol 127 1991 515 522
26. Casato M. Bonomo L. Caccavo D. Clinical effects of cyclosporin in dermatomyositis Clin Exp Dermatol 15 1990 121 123
27. Castor W.C. Bull F.E. Review of United States data on neoplasms in rheumatoid arthritis Am J Med 78 Suppl lA 1985 33 38
28. Cockburn I. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune Transplant Proc 19 1987 1804 1807
29. Cockburn I. Gotz E. Gulich A. An interim analysis of the on-going long-term safety study of cyclosporine in renal transplantation Transplant Proc 203 1988 519 529
30. Cockburn I.T.R. Krupp P. An appraisal of drug interactions with Sandimmune Transplantation Proc 21 1989 3845 3850
31. Cohen P.R. Rapini R.P. Relapsing polychondritis Int J Dermatol 25 1986 280 285
32. Connolly S.M. Sander H.M. Treatment of epidermolysis bullosa acquisita with cyclosporine [letter] J Am Acad Dermatol 16 1987 890
33. Cooper B.J. Bacal E. Patterson R. Allergic angiitis and granulomatosis. Prolonged remission induced by combined prednisoneazathioprine therapy Arch Intern Med 138 1978 376 381
34. Cooper K.D. Voorhees J.J. Fisher G.J. Effects of cyclosporine on immunologic mechanisms in psoriasis J Am Acad Dermatol 23 1990 1318 1328
35. Crawford S.E. Sherman R. Farara B. Pyoderma gangrenosum with response to cyclophosphamide therapy J Pediatr 71 1967 255 258
36. Crow L.L. Finkle J.P. Gammon W.R. Clearing of epidermolysis bullosa acquisita with cyclosporine J Am Acad Dermatol 19 1988 937 942
37. Cseuz R. Panayi G.S. The inhibition of NK cell function by azathioprine during the treatment of patients with rheumatoid arthritis Br J Rheum 29 1990 358 362
38. Cunliffe W.J. Bullous pemphigoid and response to cyclosporin Br J Dermatol 117 1987 113 114
39. Cunliffe W.J. Pemphigus foliaceous and response to cyclosporin Br J Dermatol 117 1987 114 116
40. Curley R.K. MacFarlane A.W. Vickers C.F.H. Pyoderma gangrenosum treated with cyclosporin A Br J Dermatol 113 1985 601 604
41. Danko K. Szegedi G. Cyclosporin A treatment of dermatomyositis [letter] Arthritis Rheum 34 1991 933 934
42. Davatchi F. Baygan F. Chams H. Cyclophosphamide in the treatment of the ocular manifestations of Behcet's disease J Rheumatol 11 1984 404 405
43. Davidson J.M. Lindheimer M.D. Pregnancy in women with renal allographs Semin Nephrol 4 1984 240 251
44. du Vivier A. Monro D. Verbov J. Treatment of psoriasis with azathioprine Br Med J 1 1974 49 51
45. Duschet P. Schwarz T. Oppolzer G. Persistent light reaction: Successful treatment with cyclosporin A Acta Derm Venereol (Stockh) 68 1988 176 178
46. Ebringer A. McKay I.R. Pemphigus vulgaris successfully treated with cyclophosphamide Ann Intern Med 71 1969 125 127
47. Eisen D. Ellis C.N. Duell E.A. Effect of topical cyclosporine rinse on oral lichen planus—a double-blind analysis N Engl J Med 323 1990 290 294
48. Elgart G. Larson K. Stover P. Effective treatment of pyoderma gangrenosum with cyclosporin: A report of five cases [abstract] J Invest Dermatol 92 1989 424
49. Ellis C.N. Fradin M.S. Messana J.M. Cyclosporine for plaque-type psoriasis N Engl J Med 324 1991 277 284
50. Ellis C.N. Gorsulowsky D.C. Hamilton T.A. Cyclosporine improves psoriasis in a double-blind study JAMA 256 1986 3110 3116
51. Fairchild W.V. Spence C.R. Soloman H.D. The incidence of bladder cancer after cyclophosphamide therapy J Urology 122 1979 163 164
52. Fairley J.A. Intracellular targets of cyclosporine J Am Acad Dermatol 23 1990 1329 1334
53. Fauci A.S. Haynes B.F. Katz P. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years Ann Intern Med 98 1983 76 85
54. Fauci A.S. Katz P. Haynes B.F. Cyclophosphamide therapy of severe systemic necrotizing vasculitis N Engl J Med 301 1979 235 238
55. Fellner M.J. Katz J.M. McCabe J.B. Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris Arch Dermatol 114 1978 889 894
56. Feutren G. Querin S. Tron F. The effects of cyclosporine in patients with systemic lupus Transplant Proc 4 1986 643 644
57. Fradin M.S. Ellis C.N. Voorhees J.J. Efficacy of cyclosporin A in psoriasis: A summary of the United States' experience Br J Dermatol 122 36 1990 21 25
58. Fradin M.S. Ellis C.N. Voorhees J.J. Management of patients and side effects during cyclosporine therapy for cutaneous disorders J Am Acad Dermatol 23 1990 1265 1275
59. Freeman K. Hewitt M. Warin A.P. Two cases of distinctive exudative discoid and lichenoid chronic dermatosis of Sulzberger and Garbe responding to azathioprine Br J Dermatol 111 1984 215 220
60. Fornasa C.V. Effect of local applications of cyclosporin in chronic ulcerative lichen planus [letter] Dermatologica 182 1991 65
61. Gabriel S.E. Perry H.O. Oleson G.B. Scleromyxedema. A scleroderma-like disorder with systemic manifestations Medicine 67 1988 58 65
62. Ginsburg W.W. O'Duffy J.D. Morris J.L. Multicentric reticulohistiocytosis: Response to alkylating agents in six patients Ann Intern Med 111 1989 384388
63. Ginzler E. Sharon E. Diamond H. Long-term maintenance therapy with azathioprine in systemic lupus erythematosus Arthritis Rheum 18 1975 27 34
64. Greaves M.W. Dowd P.M. Hawk J.L.M. Dermato-pharmacology: Drugs around the corner J Am Acad Dermatol 19 1988 323 329
65. Griffiths C.E.M. Powles A.V. Leonard J.N. Clearance of psoriasis with low dose cyclosporin Br Med J 293 1986 731 732
66. Gupta A.K. Brown M.D. Ellis C.N. Cyclosporine in dermatology J Am Acad Dermatol 21 1989 1245 1256
67. Gupta A.K. Ellis C.N. Cooper K.D. Oral cyclosporine A for the treatment of alopecia areata: A clinical and immunohistochemical analysis J Am Acad Dermatol 22 1990 242 250
68. Gupta A.K. Matteson E.L. Ellis C.N. Cyclosporine in the treatment of psoriatic arthritis Arch Dermatol 125 1989 507 510
69. Haim S. Friedman-Birnbaum R. Pyoderma gangrenosum in immunosuppressed patients Dermatologica 153 1976 44 48
70. Harper J.I. Zemelman V. Keat A.C.S. Cyclosporine for psoriasis: Beneficial effect in refractory skin and joint disease Transplantation Proc 20 4 1988 63 67
71. Hazelmann B.L. The comparative incidence of malignant disease in rheumatoid arthritis exposed to different treatment regimens Ann Rheum Dis 41 1982 12 17 Suppl
72. Heckmatt J. Hasson N. Saunders C. Cyclosporin in juvenile dermatomyositis Lancet 1 1989 1063 1066
73. Heule F. Van Joost T. Beukers R. Cyclosporine in the treatment of lupus erythematosus Arch Dermatol 122 1986 973 974
74. Higgins E.M. Munro C.S. Friedman P.S. Cyclosporine A in the treatment of lichen planus [letter] Arch Dermatol 125 1989 1436
75. Ho V.C. Conklin R.J. Effect of topical cyclosporine rinse on oral planus [letter] N Engl J Med 325 1981 435
76. Ho V.C. Griffiths C.E.M. Ellis C.N. Intralesional cyclosporine in the treatment of psoriasis J Am Acad Dermatol 22 1989 94 100
77. Ho V.C. Gupta A.K. Ellis C.N. Treatment of severe lichen planus with cyclosporine J Am Acad Dermatol 22 1990 64 68
78. Ho V.C. Lui H. McLean D.I. Cyclosporine in non-psoriatic dermatoses J Am Acad Dermatol 23 1990 12481259
79. Holmes R.C. A clinical and investigative study of herpes gestationis and polymorphic eruption of pregnancy [MD thesis] 1985 University of London London
80. Hoover R. Fraumeni J.F. Risk of cancer in renal transplant recipients Lancet 2 1973 55 57
81. Hunter G.A. Forbes I.J. Treatment of pityriasis rubra pilaris with azathioprine Br J Dermatol 87 1972 42 45
82. Isenberg D.A. Snaith M.L. Morrow W.J.W. Cyclosporin A for the treatment of systemic lupus erythematosus Int J Immunopharmacol 3 1981 163 169
83. Jablonska S. Chorzelski T. Immunosuppressants in the treatment of pemphigus Br J Dermatol 83 1970 315323
84. Jessen R.T. Straight M. Becker L.E. Lichen myxede-matosus: Treatment with cyclophosphamide Int J Dermatol 17 1978 833 839
85. Jones M.C. Best P.V. Catto G.R.D. Is nodular regenerative hyperplasia of the liver associated with azathioprine therapy after renal transplantation? Nephrol Dial Transplant 3 1988 331 333
86. Joss D.V. Barrett A.J. Kendra J.R. Hypertension and convulsions in children receiving cyclosporine A [letter] Lancet 1 1982 906
87. June C.H. Thompson C.B. Kennedy M.S. Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients Transplantation 41 1986 47 51
88. Kaur S. Kanwar A.J. Dexamethasone-cyclophospha-mide pulse therapy in pemphigus Int J Dermatol 29 1990 371 374
89. Kenik J.G. Fok F. Huerter C.J. Multicentric reticulohistiocytosis in a patient with malignant melanoma: A response to cyclophosphamide and a unique cutaneous feature Arthritis Rheum 33 1990 1047 1051
90. Kinlen L.J. Sheil A.G.R. Peto J. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs Br Med J 2 1979 1461 1466
91. Kirsner A.B. Farber S.J. Sheon R.P. The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis Ann Rheum Dis 41 Suppl 1 1982 32 33
92. Korstanje M.J. Van De Staak W.J.B.M. Combination-therapy cyclosporin-A-etretinate for psoriasis Clin Exp Derm 15 1990 172 173
93. Kovarsky J. Clinical pharmacology and toxicology of cyclophosphamide: Emphasis on use in rheumatic diseases Semin Arthritis Rheum 12 1983 359 368
94. Krupp P. Monka C. Side-effect profile of cyclosporin A in patients treated for psoriasis Br J Dermatol 122 Suppl 36 1990 47 56
95. Layton A.M. Cunliffe W.J. Clearing of epidermolysis bullosa acquisita with cyclosporine [letter] J Am Acad Dermatol 22 1990 535 536
96. Leib E.S. Restivo C. Paulus H.E. Immunosuppressive and corticosteroid therapy for polyarteritis nodosa Am J Med 67 1979 941 947
97. Leigh I.M. Hawk J.L. Treatment of chronic actinic dermatitis with azathioprine Br J Dermatol 110 1984 691 695
98. Levell N.J. MacLeod R.I. Marks J.M. Lack of effect of cyclosporine mouthwash in oral lichen planus [letter] Lancet 337 1991 796 797
99. Levi S. Hodgson H.J.F. Cyclosporin for dermato-myositis? Ann Rheum Dis 48 1989 85 86
100. Levine L.A. Richie J.P. Urologic complications of cyclophosphamide J Urol 141 1989 1063 1069
101. Magid M.L. Gold M.H. Treatment of recalcitrant pyoderma gangrenosum with cyclosporine [letter] J Am Acad Dermatol 20 1989 293 294
102. Mason J. Renal side-effects of cyclosporin A Br J Dermatol 122 Suppl 36 1990 71 77
103. McCune W.J. Golbus J. Zeldes W. Clinical and immunological effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus N Engl J Med 318 1988 1423 1431
104. McDonald C.J. Use of cytotoxic drugs in dermato-logic diseases. II J Am Acad Dermatol 12 1985 965 975
105. Meinardi M.M. Westerhof W. Bos J.D. Generalized pustular psoriasis (von Zumbusch) responding to cyclosporine A Br J Dermatol 116 1987 269 270
106. Merle C. Blanc D. Zultak M. Intractable epidermolysis bullosa acquisita: Efficacy of cyclosporin A Dermatologica 181 1990 44 47
107. Merot Y. Miescher P.A. Balsiger F. Cutaneous malignant melanomas occurring under cyclosporine A therapy: A report of two cases Br J Dermatol 123 1990 237 239
108. Miescher P.A. Favre H. Mihatsch M.J. The place of cyclosporine A in the treatment of connective tissue diseases Transplant Proc 3 1988 224 237
109. Mihatsch M.J. Belghiti D. Bohman S.O. Kidney biopsies in control of cyclosporin A-treated psoriatic patients Br J Dermatol 122 Suppl 36 1990 95 100
110. Mondino B.J. Brown S.I. Immunosuppressive therapy in ocular cicatricial pemphigoid Am J Ophthalmol 96 1983 453 459
111. Moore M.J. Clinical pharmacokinetics of cyclophosphamide Clin Pharmacokinet 20 1991 194 208
112. Morrison J.G.L. Schultz E.J. Treatment of eczema with cyclophosphamide and azathioprine Br J Dermatol 98 1978 203 207
113. Munro C.S. Higgins E.M. Marks J.M. Cyclosporin A in atopic dermatitis: Therapeutic response is dissociated from effects on allergic reactions Br J Dermatol 124 1991 43 48
114. Napoleon F.M.B. Berger F. Chevallier M. Azathioprine induced liver disease: Nodular regenerative hyperplasia of the liver and previous fibrosis in a patient treated for multiple sclerosis Gut 32 1991 715 717
115. Newell L.M. Malkinson F.D. Pyoderma gangrenosum. Response to cyclophosphamide therapy Arch Dermatol 119 1983 495 497
116. Norris P.G. Camp R.D.R. Hawk J.L.M. Actinic reticu-loid: Response to cyclosporine J Am Acad Dermatol 21 1989 307 309
117. Omerod A.D. Duncan J. Stankler L. Benign familial pemphigus responsive to cyclosporin, a possible role for cellular immunity in pathogenesis Br J Dermatol 124 1991 299 305
118. Pacheco Y. Marechal C. Marechal F. Azathioprine treatment of chronic pulmonary sarcoidosis Sarcoidosis 2 1985 107 113
119. Pasricha J.S. Thanzama J. Khan U.K. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus Br J Dermatol 119 1988 73 77
120. Penmetcha M. Navaratnam A. Pyoderma gangrenosum: Response to cyclosporin A Int J Dermatol 27 1988 253
121. Penn I. Cancer in immunosuppressed patients Transplant Proc 16 1984 492 494
122. Penn I. Depressed immunity and the development of cancer Clin Exp Immunol 46 1981 459 475
123. Penn I. Starzl T.E. A summary of the status of de novo cancer in transplant recipients Transplant Proc 4 1972 719 732
124. Peter R.U. Ruzicka T. Eckert F. Low-dose cyclosporine A in the treatment of disabling morphea Arch Dermatol 127 1991 1420
125. Pettersson T. Kariniemi A.L. Franssila K. Treatment of cytophagic histiocytic panniculitis with combination chemotherapy Eur J Hematol 44 1990 77 78
126. Petzelbauer P. Honigsmann H. Langer K. Cyclosporine A in combination with photochemo-therapy (PUVA) in the treatment of psoriasis Br J Dermatol 123 1990 641 647
127. Picascia D.D. Garden J.M. Freinkel R.K. Treatment of resistant severe psoriasis with systemic cyclosporine J Am Acad Dermatol 17 1987 408 414
128. Picascia D.D. Roenigk H.H. Jr Effects of oral and topical cyclosporine in male pattern alopecia Transplant Proc 3 1988 109 111
129. Powles A.V. Baker B.S. McFadden J. Intrale-sional injection of cyclosporin in psoriasis Lancet 1 1989 537
130. Roenigk H.H. Deodhar S. Pemphigus treatment with azathioprine. Clinical and immunologic correlation Arch Dermatol 107 1973 353 357
131. Roper S.S. Spraker M.K. Cutaneous histiocytosis syndromes Pediatr Dermatol 3 1985 19 30
132. Russel-Jones R. Azathioprine therapy in the management of persistent erythema multiforme Br J Dermatol 105 1981 465 468
133. Saway P.A. Heck L.W. Bonner J.R. Azathioprine hypersensitivity Am J Med 84 1988 960 964
134. Schmidt J.B. Gebhart W. Kopsa H. Does cyclosporine A influence sex hormone level? Exp Clin Endocrinol 88 1986 207 211
135. Schulz E.J. Menter M.A. Treatment of discoid and subacute lupus erythematosus with cyclophosphamide Br J Dermatol 85 7 1971 60 65
136. Shehade S. Successful treatment of generalized discoid skin lesions with azathioprine Arch Dermatol 122 1986 376 377
137. Shelley E.D. Shelley W.B. Cyclosporine therapy for pyoderma gangrenosum associated with sclerosing cholangitis and ulcerative colitis J Am Acad Dermatol 18 1988 1084 1088
138. Silman A.J. Petrie J. Hazleman B. Lymphopro-liferative cancer and other malignancies in patients with rheumatoid arthritis treated with azathioprine: A 20-year follow-up study Ann Rheum Dis 47 1988 988 992
139. Singh G. Fries J.F. Spitz P. Toxic effects of azathioprine in rheumatoid arthritis: A national post-marketing perspective Arthritis Rheum 32 7 1989 837 843
140. Sowden J.M. Berth-Jones J. Ross J.S. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis Lancet 338 1991 137 140
141. Spiers A.S.P. Chikkappa G. Wilbur H.J. Hemorrhagic cystitis after low-dose cyclophosphamide [letter] Lancet 1 1983 1213
142. Steigerwald J.C. Progressive systemic sclerosis. Management: III. Immunosuppressive agents Clin Rheum Dis 5 1979 284 294
143. Steinsson K. Jonsdottir I. Valdimarsson H. Cyclosporin A in psoriatic arthritis: An open study Ann Rheum Dis 49 1990 603 606
144. Stevens J.E. Villoughly D.A. The anti-inflammatory effect of some immunosuppressive agents J Pathol 97 1968 367 373
145. Stillwell T.J. Benson R.C. Jr Cyclophosphamide-in-duced hemorrhagic cystitis—a review of 100 patients Cancer 61 1988 451
146. Tappeiner G. Groh V. Treatment of pemphigus with cyclosporin Schindler R. Cyclosporin in Autoimmune Diseases 1985 Springer-Verlag New York 205 208
147. Taylor R.S. Cooper K.D. Headington J.T. Cyclosporine therapy for severe atopic dermatitis J Am Acad Dermatol 21 1989 580 583
148. Thestrup-Pedersen K. Zachariae C. Kaltoft K. Development of cutaneous pseudolymphoma following cyclosporin therapy of actinic reticuloid Dermatologica 177 1988 376 381
149. Thivolet J. Barthelemy H. Rigot-Muller G. Effects of cyclosporin on bullous pemphigoid and pemphigus Lancet 1 1985 334 335
150. Toonstra J. Henquet C.J.M. van Weelden H. Actinic reticuloid: A clinical, photobiologic, histopathologic, and follow-up study of 16 patients J Am Acad Dermatol 21 1989 205 214
151. Tsokos G. Caughman S.W. Klippel J.H. Successful treatment of generalized discoid skin lesions with azathioprine Arch Dermatol 121 1985 1323 1325
152. Van Wanghe P. Dequeker J. Compliance and long-term effect of azathioprine in 65 rheumatoid arthritis cases Ann Rheum Dis 41 Suppl l 1982 40 43
153. Voogd C.E. Azathioprine, a genotoxic agent to be considered non-genotoxic in man Mutation Research 1989 133 152
154. Wahlgren C.F. Scheynius A. Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis Acta Derm Venereol (Stockh) 70 1990 323 329
155. Watkins P.B. The role of cytochrome P-450 in cyclosporine metabolism J Am Acad Dermatol 23 1990 13011311
156. Wentzell J.M. Baughman R.D. O'Connor G.T. Cyclosporine in the treatment of psoriasis Arch Dermatol 123 1987 163 165
157. Whisnant J.K. Pelkey J. Rheumatoid arthritis: Treatment with azathioprine: Clinical side effects and laboratory abnormalities Ann Rheum Dis 41 Suppl 1 1982 44 47
158. Woolfson H. Acne fulminans with circulating immune complexes and leukemoid reaction treated with steroids and azathioprine Clin Exp Dermatol 12 1987 463 466
159. Yazici H. Pazarli H. Barnes C.G. A controlled trial of azathioprine in Behcet's syndrome N Engl J Med 322 1990 281 285
160. Yee G.C. Pharmacokinetic interactions between cyclosporine and other drugs Transplantation Proc 22 1990 1203 1207
161. Yocum D.E. Wilder R.L. Cyclosporine A in progressive systemic sclerosis Am J Med 83 1987 369 370
162. Younger I.R. Harris D.W.S. Colver G.B. Azathioprine in dermatology J Am Acad Dermatol 25 1991 281 286
163. Zachariae H. Cyclosporine A in epidermolysis bullosa acquisita J Am Acad Dermatol 17 1987 1058 1059
164. Zachariae H. Kragbelle K. Hansen H.E. Changes in renal biopsies during low dose cyclosporine treatment [letter] Acta Derm Venereol 70 1990 361 362
165. Zachariae H. Thestrup-Pedersen K. Cyclosporine A in acrodermatitis continua Dermatologica 175 1987 29 32